MAPK cascade | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
natural killer cell differentiation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
negative regulation of T cell mediated cytotoxicity | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of T cell mediated cytotoxicity | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
negative regulation of cytokine-mediated signaling pathway | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
hematopoietic progenitor cell differentiation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of immunoglobulin production | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of humoral immune response mediated by circulating immunoglobulin | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
negative regulation of protein kinase activity | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
protein dephosphorylation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
negative regulation of cell adhesion involved in substrate-bound cell migration | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
leukocyte cell-cell adhesion | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
cell surface receptor signaling pathway | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
response to gamma radiation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
regulation of gene expression | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
dephosphorylation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
B cell differentiation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
T cell differentiation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of B cell proliferation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
negative regulation of protein autophosphorylation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
regulation of interleukin-8 production | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
negative regulation of interleukin-2 production | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of interleukin-2 production | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of tumor necrosis factor production | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
heterotypic cell-cell adhesion | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
B cell proliferation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of T cell proliferation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
T cell activation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
gamma-delta T cell differentiation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of MAPK cascade | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
cell cycle phase transition | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive thymic T cell selection | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
negative thymic T cell selection | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of gamma-delta T cell differentiation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of protein kinase activity | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
regulation of receptor signaling pathway via JAK-STAT | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
alpha-beta T cell proliferation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of alpha-beta T cell proliferation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of isotype switching to IgG isotypes | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
bone marrow development | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
stem cell development | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of peptidyl-tyrosine phosphorylation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
negative regulation of peptidyl-tyrosine phosphorylation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
regulation of phagocytosis | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of phagocytosis | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of calcium-mediated signaling | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
T cell receptor signaling pathway | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
B cell receptor signaling pathway | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
regulation of T cell receptor signaling pathway | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of antigen receptor-mediated signaling pathway | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
release of sequestered calcium ion into cytosol | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
defense response to virus | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
regulation of cell cycle | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of Fc receptor mediated stimulatory signaling pathway | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
regulation of protein tyrosine kinase activity | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
negative regulation of ERK1 and ERK2 cascade | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of ERK1 and ERK2 cascade | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
extrinsic apoptotic signaling pathway | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
negative regulation of microglial cell activation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
response to aldosterone | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
DN2 thymocyte differentiation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of hematopoietic stem cell migration | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of stem cell proliferation | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
positive regulation of extrinsic apoptotic signaling pathway | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) |
cell adhesion | Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) |
cell surface receptor protein tyrosine phosphatase signaling pathway | Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) |
cell migration | Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) |
neuron projection regeneration | Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) |
peptidyl-tyrosine dephosphorylation | Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) |
regulation of axon regeneration | Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) |
synaptic membrane adhesion | Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) |
negative regulation of receptor binding | Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) |
negative regulation of transcription by RNA polymerase II | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of cell population proliferation | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
insulin receptor signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of tumor necrosis factor-mediated signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of lipid storage | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
B cell differentiation | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
T cell differentiation | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
erythrocyte differentiation | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
peptidyl-tyrosine dephosphorylation | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
insulin receptor recycling | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of epidermal growth factor receptor signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of tyrosine phosphorylation of STAT protein | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
glucose homeostasis | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of macrophage differentiation | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
positive regulation of gluconeogenesis | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of insulin receptor signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of inflammatory response | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of T cell receptor signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of chemotaxis | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
regulation of type II interferon-mediated signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of type II interferon-mediated signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of type I interferon-mediated signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of interleukin-6-mediated signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of ERK1 and ERK2 cascade | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
regulation of hepatocyte growth factor receptor signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of interleukin-2-mediated signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of interleukin-4-mediated signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of macrophage colony-stimulating factor signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of positive thymic T cell selection | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
positive regulation of PERK-mediated unfolded protein response | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
negative regulation of receptor signaling pathway via JAK-STAT | Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) |
positive regulation of JUN kinase activity | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
protein dephosphorylation | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
insulin receptor signaling pathway | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
regulation of signal transduction | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
negative regulation of signal transduction | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
actin cytoskeleton organization | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
regulation of endocytosis | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
negative regulation of vascular endothelial growth factor receptor signaling pathway | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
endoplasmic reticulum unfolded protein response | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
regulation of intracellular protein transport | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
cellular response to unfolded protein | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
peptidyl-tyrosine dephosphorylation | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
platelet-derived growth factor receptor-beta signaling pathway | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
IRE1-mediated unfolded protein response | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
insulin receptor recycling | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
negative regulation of MAP kinase activity | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
negative regulation of insulin receptor signaling pathway | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
regulation of type I interferon-mediated signaling pathway | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
growth hormone receptor signaling pathway via JAK-STAT | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
positive regulation of protein tyrosine kinase activity | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
negative regulation of ERK1 and ERK2 cascade | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
regulation of hepatocyte growth factor receptor signaling pathway | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
positive regulation of IRE1-mediated unfolded protein response | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
negative regulation of PERK-mediated unfolded protein response | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
positive regulation of receptor catabolic process | Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) |
integrin-mediated signaling pathway | Receptor-type tyrosine-protein phosphatase alpha | Homo sapiens (human) |
insulin receptor signaling pathway | Receptor-type tyrosine-protein phosphatase alpha | Homo sapiens (human) |
modulation of chemical synaptic transmission | Receptor-type tyrosine-protein phosphatase alpha | Homo sapiens (human) |
regulation of focal adhesion assembly | Receptor-type tyrosine-protein phosphatase alpha | Homo sapiens (human) |
protein dephosphorylation | Receptor-type tyrosine-protein phosphatase alpha | Homo sapiens (human) |
protein dephosphorylation | Receptor-type tyrosine-protein phosphatase beta | Homo sapiens (human) |
phosphate-containing compound metabolic process | Receptor-type tyrosine-protein phosphatase beta | Homo sapiens (human) |
glial cell migration | Receptor-type tyrosine-protein phosphatase beta | Homo sapiens (human) |
dephosphorylation | Receptor-type tyrosine-protein phosphatase beta | Homo sapiens (human) |
angiogenesis | Receptor-type tyrosine-protein phosphatase beta | Homo sapiens (human) |
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | Receptor-type tyrosine-protein phosphatase beta | Homo sapiens (human) |
protein dephosphorylation | Receptor-type tyrosine-protein phosphatase epsilon | Homo sapiens (human) |
negative regulation of insulin receptor signaling pathway | Receptor-type tyrosine-protein phosphatase epsilon | Homo sapiens (human) |
MAPK cascade | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
hematopoietic progenitor cell differentiation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
negative regulation of humoral immune response mediated by circulating immunoglobulin | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
protein dephosphorylation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
G protein-coupled receptor signaling pathway | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
positive regulation of cell population proliferation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
negative regulation of cell population proliferation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
negative regulation of angiogenesis | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
peptidyl-tyrosine phosphorylation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
cytokine-mediated signaling pathway | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
cell differentiation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
platelet formation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
T cell costimulation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
negative regulation of interleukin-6 production | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
negative regulation of tumor necrosis factor production | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
negative regulation of mast cell activation involved in immune response | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
positive regulation of cell adhesion mediated by integrin | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
peptidyl-tyrosine dephosphorylation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
megakaryocyte development | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
T cell proliferation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
negative regulation of T cell proliferation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
natural killer cell mediated cytotoxicity | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
regulation of apoptotic process | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
negative regulation of MAPK cascade | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
regulation of B cell differentiation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
negative regulation of peptidyl-tyrosine phosphorylation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
T cell receptor signaling pathway | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
B cell receptor signaling pathway | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
negative regulation of T cell receptor signaling pathway | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
regulation of release of sequestered calcium ion into cytosol | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
regulation of type I interferon-mediated signaling pathway | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
regulation of ERK1 and ERK2 cascade | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
platelet aggregation | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
negative regulation of inflammatory response to wounding | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
epididymis development | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
regulation of G1/S transition of mitotic cell cycle | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
intracellular signal transduction | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
mitotic cell cycle | Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) |
regulation of cell growth | Type-1 angiotensin II receptor | Homo sapiens (human) |
kidney development | Type-1 angiotensin II receptor | Homo sapiens (human) |
renin-angiotensin regulation of aldosterone production | Type-1 angiotensin II receptor | Homo sapiens (human) |
maintenance of blood vessel diameter homeostasis by renin-angiotensin | Type-1 angiotensin II receptor | Homo sapiens (human) |
regulation of systemic arterial blood pressure by renin-angiotensin | Type-1 angiotensin II receptor | Homo sapiens (human) |
G protein-coupled receptor signaling pathway | Type-1 angiotensin II receptor | Homo sapiens (human) |
phospholipase C-activating G protein-coupled receptor signaling pathway | Type-1 angiotensin II receptor | Homo sapiens (human) |
positive regulation of cytosolic calcium ion concentration | Type-1 angiotensin II receptor | Homo sapiens (human) |
Rho protein signal transduction | Type-1 angiotensin II receptor | Homo sapiens (human) |
positive regulation of macrophage derived foam cell differentiation | Type-1 angiotensin II receptor | Homo sapiens (human) |
regulation of vasoconstriction | Type-1 angiotensin II receptor | Homo sapiens (human) |
calcium-mediated signaling | Type-1 angiotensin II receptor | Homo sapiens (human) |
positive regulation of phospholipase A2 activity | Type-1 angiotensin II receptor | Homo sapiens (human) |
low-density lipoprotein particle remodeling | Type-1 angiotensin II receptor | Homo sapiens (human) |
regulation of renal sodium excretion | Type-1 angiotensin II receptor | Homo sapiens (human) |
angiotensin-activated signaling pathway | Type-1 angiotensin II receptor | Homo sapiens (human) |
regulation of cell population proliferation | Type-1 angiotensin II receptor | Homo sapiens (human) |
symbiont entry into host cell | Type-1 angiotensin II receptor | Homo sapiens (human) |
regulation of inflammatory response | Type-1 angiotensin II receptor | Homo sapiens (human) |
positive regulation of inflammatory response | Type-1 angiotensin II receptor | Homo sapiens (human) |
positive regulation of protein metabolic process | Type-1 angiotensin II receptor | Homo sapiens (human) |
cell chemotaxis | Type-1 angiotensin II receptor | Homo sapiens (human) |
phospholipase C-activating angiotensin-activated signaling pathway | Type-1 angiotensin II receptor | Homo sapiens (human) |
blood vessel diameter maintenance | Type-1 angiotensin II receptor | Homo sapiens (human) |
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis | Type-1 angiotensin II receptor | Homo sapiens (human) |
positive regulation of CoA-transferase activity | Type-1 angiotensin II receptor | Homo sapiens (human) |
positive regulation of reactive oxygen species metabolic process | Type-1 angiotensin II receptor | Homo sapiens (human) |
inflammatory response | Type-1 angiotensin II receptor | Homo sapiens (human) |
blood vessel remodeling | Type-2 angiotensin II receptor | Homo sapiens (human) |
regulation of systemic arterial blood pressure by circulatory renin-angiotensin | Type-2 angiotensin II receptor | Homo sapiens (human) |
angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure | Type-2 angiotensin II receptor | Homo sapiens (human) |
brain renin-angiotensin system | Type-2 angiotensin II receptor | Homo sapiens (human) |
cell surface receptor signaling pathway | Type-2 angiotensin II receptor | Homo sapiens (human) |
G protein-coupled receptor signaling pathway | Type-2 angiotensin II receptor | Homo sapiens (human) |
G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger | Type-2 angiotensin II receptor | Homo sapiens (human) |
brain development | Type-2 angiotensin II receptor | Homo sapiens (human) |
regulation of blood pressure | Type-2 angiotensin II receptor | Homo sapiens (human) |
negative regulation of heart rate | Type-2 angiotensin II receptor | Homo sapiens (human) |
negative regulation of cell growth | Type-2 angiotensin II receptor | Homo sapiens (human) |
positive regulation of phosphoprotein phosphatase activity | Type-2 angiotensin II receptor | Homo sapiens (human) |
regulation of metanephros size | Type-2 angiotensin II receptor | Homo sapiens (human) |
exploration behavior | Type-2 angiotensin II receptor | Homo sapiens (human) |
nitric oxide-cGMP-mediated signaling | Type-2 angiotensin II receptor | Homo sapiens (human) |
angiotensin-activated signaling pathway | Type-2 angiotensin II receptor | Homo sapiens (human) |
vasodilation | Type-2 angiotensin II receptor | Homo sapiens (human) |
negative regulation of blood vessel endothelial cell migration | Type-2 angiotensin II receptor | Homo sapiens (human) |
positive regulation of DNA-templated transcription | Type-2 angiotensin II receptor | Homo sapiens (human) |
negative regulation of neurotrophin TRK receptor signaling pathway | Type-2 angiotensin II receptor | Homo sapiens (human) |
neuron apoptotic process | Type-2 angiotensin II receptor | Homo sapiens (human) |
positive regulation of metanephric glomerulus development | Type-2 angiotensin II receptor | Homo sapiens (human) |
positive regulation of branching involved in ureteric bud morphogenesis | Type-2 angiotensin II receptor | Homo sapiens (human) |
positive regulation of extrinsic apoptotic signaling pathway | Type-2 angiotensin II receptor | Homo sapiens (human) |
inflammatory response | Type-2 angiotensin II receptor | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |